Novo Nordisk A/S (NOV.DE)

EUR 54.73

(0.9%)

Eps Summary of Novo Nordisk A/S

  • Novo Nordisk A/S's latest annual eps in 2023 was 18.67 DKK , up 52.44% from previous year.
  • Novo Nordisk A/S's latest quarterly eps in 2024 Q2 was 0.60 DKK , down -21.05% from previous quarter.
  • Novo Nordisk A/S reported an annual eps of 1.64 DKK in 2022, up 17.14% from previous year.
  • Novo Nordisk A/S reported an annual eps of 1.40 DKK in 2021, up 15.7% from previous year.
  • Novo Nordisk A/S reported a quarterly eps of 0.76 DKK for 2024 Q1, up 15.85% from previous quarter.
  • Novo Nordisk A/S reported a quarterly eps of N/A for 2023 FY, up 52.44% from previous quarter.

Annual Eps Chart of Novo Nordisk A/S (2023 - 2016)

Historical Annual Eps of Novo Nordisk A/S (2023 - 2016)

Year Eps Eps Growth
2023 18.67 DKK 52.44%
2022 1.64 DKK 17.14%
2021 1.40 DKK 15.7%
2020 1.21 DKK 10.0%
2019 1.10 EUR 2.8%
2018 1.07 EUR 2.88%
2017 1.04 EUR 2.97%
2016 1.01 EUR 0.0%

Peer Eps Comparison of Novo Nordisk A/S

Name Eps Eps Difference
BioNTech SE 3.87 EUR -382.429%
CureVac N.V. -1.18 EUR 1682.203%
Biotest Aktiengesellschaft 3.21 EUR -481.62%
Biotest Aktiengesellschaft 3.21 EUR -481.62%
BRAIN Biotech AG -0.38 EUR 5013.158%
Formycon AG 4.76 EUR -292.227%
Heidelberg Pharma AG -0.44 EUR 4343.182%
Medigene AG -0.66 EUR 2928.788%